Pharmacokinetics of Celecoxib in Children

1

Review clinical trials related to Pharmacokinetics of Celecoxib in Children. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

CELECOXIB Plasma and Cerebral Spinal Fluid Pharmacokinetics in Children

Celecoxib is effective for reducing postoperative pain in adults. Children use celecoxib more rapidly than adults and require higher doses. Celecoxib is partially metabolized in the liver by a certain enzyme. A person's genetic variation of this enzyme can influence how well their body uses Celecoxib. Furthermore, Celecoxib down-regulates P-glycoprotein (P-gp), a drug efflux transporter located at the blood brain barrier responsible for central nervous system (CNS) extrusion of ondansetron and possibly fentanyl; therefore celecoxib may augment the CNS effects of these drugs. Understanding the blood and cerebrospinal fluid (CSF) profile of celecoxib in children and the influence of genetics on metabolism would help to develop appropriate celecoxib dosing in children for various treatment options.

Participants needed: 65
Trial details
Phase: Phase 2Age: 2-12Biological sex: AllType: InterventionalSponsor: Children's Hospital of Eastern OntarioUpdated: Feb 8, 2024Locations: 1
Eligibility criteria

Age < 2yrs and >12yrs old [+16]